bitop AG and JGL d.d. Croatia signed License and Supply Agreement for Ectoin® Allergy Nasal Spray

bitop AG today announced that it has recently entered into an exclusive license and supply agreement with JADRAN-GALENSKI LABORATORIJ d.d. (JGL d.d.) for bitop’s Ectoin® Allergy Nasal Spray 2%. Under this agreement, JGL d.d. will have the right to sell the nasal spray under its Aqua Maris® brand in various countries of the CEE and CIS regions. The agreement is valid for 3 years. The sale of the product with the name Aqua Maris® Ektoin has just started in Croatia.

bitop AG is confident that with JGL d.d., top manufacturer of seawater preparations in the world, it has chosen a partner with an in-depth understanding of the seawater-based nasal spray market in the CEE and CIS regions.

Allergic rhinitis is becoming more widespread, especially in developed western countries. It is characterized by sneezing, as well as an itchy, runny or congested nose. Symptomatic treatment of the disease with the currently available OTC products leaves room for improvement. Regardless of the used product, many patients complain about incomplete control of symptoms. In addition, bothersome adverse effects of allergic rhinitis medications such as bad taste, drowsiness and fatigue are well known and not yet entirely overcome. bitop AG`s Ectoin® Allergy Nasal Spray 2% is a unique product that combines the inflammation-reducing and symptom-alleviating properties of Ectoin® with the cleaning and moisturizing properties of salt solutions. In case of an allergic rhinitis it alleviates the nasal symptoms of the allergy, cleans the nasal cavities and prevents the occurrence of new symptoms all combined with a very good safety profile.

Ectoin® is a natural compound firstly found in a desert. There it protects microorganisms from hostile conditions. Used in humans, it has inflammation-reducing, cell-protective and regenerative properties. Due to its excellent safety profile, it can be used in products for young, elderly, and sensitive persons.

bitop AG, a German company founded in 1993, is focused on the development of Ectoin®-containing medical devices. Besides its Ectoin® Allergy Nasal Spray 2%, it is offering nasal sprays for the symptomatic treatment of acute rhinosinusitis and rhinitis sicca, eye drops for the treatment of symptoms in case of an allergic conjunctivitis or dry eye syndrome or creams which alleviate symptoms in case of inflammatory skin diseases. bitop AG is worldwide the only manufacturer of Ectoin®.

JGL d.d. is a Croatian pharmaceutical company from Rijeka with more than 20 years’ experience in selling health products. Its product range comprises a wide range of generic drugs and has a special focus on preparations for the senses and preparations based on seawater. The Aqua Maris® brand was launched in the second half of 1999. Today, Aqua Maris® is present in 32 countries on three continents with a product line of over twenty well established natural solution products for ORL problems. The Aqua Maris® brand is built on expert pharmaceutical knowledge about recognized benefits of seawater for respiratory health which enables it to be trusted by physicians, pharmacists and users alike. The healing properties of Aqua Maris® products are derived from the Adriatic Sea, one of the cleanest seas in Europe. The benefits of seawater for a healthy respiratory tract are widely recognized, and the Adriatic is rich in more than 80 essential minerals and oligoelements.

bitop AG
Dr. Silke Behne
Stockumer Strasse 28
58453 Witten
Germany
Phone:+49 2302 91 44 00
E-mail: info@bitop.de
Internet: www.bitop.de

This release was published on openPR.